跳至主要内容
临床试验/NCT07507669
NCT07507669尚未招募不适用

Evaluation of MetaCalm at Two Dose Levels in Healthy Adults With Acute Stress: An Open-Label, Non-Randomized Clinical Study

Metagenics, Inc.1 个研究点 分布在 1 个国家目标入组 280 人开始时间: 2026年4月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
280
试验地点
1
主要终点
STAI (State-Trait-Anxiety-Inventory) questionnaire

研究概览

简要总结

This Open-Label, Non-Randomized Clinical Study involving 280 participants who will undergo a total participation of 6 hours.

详细描述

The trial begins with a screening process to assess eligibility for the study. Participants will then receive 2 or 4 MetaCalm chewable tablets, followed by a 6-hour phase during which they will be asked to complete several questionnaires at different times after taking the tablets.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Providing written informed consent
  • Males and females of at least 18 years old
  • Obtaining a reference score of ≥ 30 on the STAI questionnaire (State-Trait Anxiety Inventory, short version, 10-item scale)

排除标准

  • Being on anxiolytic and beta blocker treatment
  • Individuals who use illicit or recreational drugs
  • Having consumed adaptogen plants in one week prior to enrollment
  • Participating in another clinical trial
  • Patients diagnosed with cancer
  • Allergic to any of the ingredients in this product
  • Obtaining a reference score of less than 30 on the STAI questionnaire (State-Trait Anxiety Inventory, short version, 10-item scale)

研究组 & 干预措施

2 chewable tablets of MetaCalm

Active Comparator

Selection, during which eligibility to participate in the trial takes place at the start of the study: A single dose of 2 chewable tablets is administered.

干预措施: 2 chewable tablets of MetaCalm (Dietary Supplement)

4 chewable tablets of MetaCalm

Active Comparator

Selection, during which eligibility to participate in the trial takes place at the start of the study: A single dose of 4 chewable tablets is administered.

干预措施: 4 chewable tablets of MetaCalm (Dietary Supplement)

结局指标

主要结局

STAI (State-Trait-Anxiety-Inventory) questionnaire

时间窗: 5 measurements in 6 hours

To assess the impact of MetaCalm on stress using a validated questionnaire, the State-Trait Anxiety Inventory (STAI) for adults. Depending on the patient's stress levels, scores will range from 10 to 40. The higher the score, the more stressed the patient is considered to be.

次要结局

  • Hunger, appetite and craving impacts(5 measurements in 6 hours)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验